You searched for "examination"
ANTS Imaging Competition 2025
The ANTerior Segment Imaging Competition from Eye News and Keeler promotes and celebrates the work of slit-lamp imaging, culminating in cash prizes and exposure for its winners. After a successful run in 2024, the ANTS Imaging Competition returned this year...Rb-NET: a network to save life and preserve vision in children in Africa
Responding to need is a key element underpinning the VISION 2020 LINKS Programme [1]. It is embedded in the process through which LINKS are established, with institutions in low- and middle-income countries (LMICs) first defining their priority areas of training...Postgraduate training for ophthalmic practitioners
The UK currently spends £25 billion per year on ocular disease, and there is expected to be a 40% increase in those affected by visual impairment by 2050 [1]. To manage this demand, 82% of ophthalmology units across the UK...Leicester Community Eye Hospital recognised as ‘Good’
Care and Quality Commission awards CHEC coveted quality rating.
Atlas of Glaucoma Third edition
Glaucoma patients constitute a significant proportion of any ophthalmology clinic. Hence, a basic understanding, evaluation and management of the condition form part of the essential clinical skillset of any ophthalmologist. Atlas of Glaucoma is a good read and very useful...
Nerve head in healthy humans using OCT-angiography
Optical coherence tomography angiography (OCT-A) is a recent, dyeless, and noninvasive imaging technique for evaluating depth-resolved vascular status by capturing the dynamic motion of the erythrocytes. It provides the flow map of major vessels and capillary plexuses separately in different...
Retreatment of myopic LASIK with femtosecond and custom ablation
The purpose of this study was to identify the risk factors for retreatment post laser in situ keratomileusis (LASIK). A retrospective chart review was carried out for a four-year period and all patients who had undergone LASIK at the Boston...
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...
Non-arteritic anterior ischaemic optic neuropathy in the Asian population
This article provides an evaluation of changes in visual function associated with non-arteritic anterior ischaemic optic neuropathy (NAION) among Korean patients. Visual changes were identified as a reduction in visual acuity by three Snellen lines or a deterioration of visual...
Cataract surgery in patients with retinitis pigmentosa
Retinitis pigmentosa (RP) is the commonest inherited cause of retinal degeneration. Posterior subcapsular cataract (PSC) develops in 41% to 90% of these patients by age 40 years. In this retrospective study, the authors have evaluated surgical outcomes in patients with...
Atrophy and anti-VEGF
The aim of this study was to investigate treatment factors, along with ocular and systemic factors for their association with macular atrophy (MA) incidence in eyes with neovascular age-related macular degeneration (nAMD) treated with anti-VEGF aflibercept or ranibizumab according to...
